These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation. Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203 [TBL] [Abstract][Full Text] [Related]
3. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas. Schieffer KM; Agarwal V; LaHaye S; Miller KE; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly BJ; Crist E; Rusin J; Finlay JL; Osorio DS; Sribnick EA; Leonard JR; Feldman A; Orr BA; Serrano J; Vasudevaraja V; Snuderl M; White P; Magrini V; Wilson RK; Mardis ER; Boué DR; Cottrell CE Am J Surg Pathol; 2021 Mar; 45(3):329-340. PubMed ID: 33074854 [TBL] [Abstract][Full Text] [Related]
4. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes. Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701 [TBL] [Abstract][Full Text] [Related]
5. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma. Paramasivam N; Hübschmann D; Toprak UH; Ishaque N; Neidert M; Schrimpf D; Stichel D; Reuss D; Sievers P; Reinhardt A; Wefers AK; Jones DTW; Gu Z; Werner J; Uhrig S; Wirsching HG; Schick M; Bewerunge-Hudler M; Beck K; Brehmer S; Urbschat S; Seiz-Rosenhagen M; Hänggi D; Herold-Mende C; Ketter R; Eils R; Ram Z; Pfister SM; Wick W; Weller M; Grossmann R; von Deimling A; Schlesner M; Sahm F Acta Neuropathol; 2019 Aug; 138(2):295-308. PubMed ID: 31069492 [TBL] [Abstract][Full Text] [Related]
6. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas. Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425 [TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of synchronous intracranial meningiomas with different histological grades. Chowdhury T; Yoo Y; Seo Y; Dho YS; Kim S; Choi A; Choi M; Park SH; Park CK; Lee SH; Lee JY J Neurooncol; 2018 May; 138(1):41-48. PubMed ID: 29423538 [TBL] [Abstract][Full Text] [Related]
8. Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design. Everson RG; Hashimoto Y; Freeman JL; Hodges TR; Huse J; Zhou S; Xiu J; Spetzler D; Sanai N; Kim L; Kesari S; Brenner A; De Monte F; Heimberger A; Raza SM J Neurooncol; 2018 Sep; 139(2):469-478. PubMed ID: 29846894 [TBL] [Abstract][Full Text] [Related]
9. Inversion-mediated gene fusions involving NAB2-STAT6 in an unusual malignant meningioma. Gao F; Ling C; Shi L; Commins D; Zada G; Mack WJ; Wang K Br J Cancer; 2013 Aug; 109(4):1051-5. PubMed ID: 23860521 [TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules. Torres-Martín M; Kusak ME; Isla A; Burbano RR; Pinto GR; Melendez B; Castresana JS; Rey JA Cancer Genet; 2015 Jun; 208(6):327-32. PubMed ID: 25981829 [TBL] [Abstract][Full Text] [Related]
11. Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system. Yuzawa S; Nishihara H; Yamaguchi S; Mohri H; Wang L; Kimura T; Tsuda M; Tanino M; Kobayashi H; Terasaka S; Houkin K; Sato N; Tanaka S Mod Pathol; 2016 Jul; 29(7):708-16. PubMed ID: 27102344 [TBL] [Abstract][Full Text] [Related]
12. Genomic profile of human meningioma cell lines. Mei Y; Bi WL; Greenwald NF; Agar NY; Beroukhim R; Dunn GP; Dunn IF PLoS One; 2017; 12(5):e0178322. PubMed ID: 28552950 [TBL] [Abstract][Full Text] [Related]
14. Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5. Abedalthagafi MS; Merrill PH; Bi WL; Jones RT; Listewnik ML; Ramkissoon SH; Thorner AR; Dunn IF; Beroukhim R; Alexander BM; Brastianos PK; Francis JM; Folkerth RD; Ligon KL; Van Hummelen P; Ligon AH; Santagata S Oncotarget; 2014 Nov; 5(21):10596-606. PubMed ID: 25347344 [TBL] [Abstract][Full Text] [Related]
15. NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas. Vasan V; Dullea JT; Devarajan A; Ali M; Rutland JW; Gill CM; Kinoshita Y; McBride RB; Gliedman P; Bederson J; Donovan M; Sebra R; Umphlett M; Shrivastava RK J Neurooncol; 2023 Jan; 161(2):309-316. PubMed ID: 36436149 [TBL] [Abstract][Full Text] [Related]
16. SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas. Boetto J; Bielle F; Sanson M; Peyre M; Kalamarides M Neuro Oncol; 2017 Mar; 19(3):345-351. PubMed ID: 28082415 [TBL] [Abstract][Full Text] [Related]
17. Clonal analysis of a case of multiple meningiomas using multiple molecular genetic approaches: pathology case report. Zhu JJ; Maruyama T; Jacoby LB; Herman JG; Gusella JF; Black PM; Wu JK Neurosurgery; 1999 Aug; 45(2):409-16. PubMed ID: 10449091 [TBL] [Abstract][Full Text] [Related]
18. Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas. Lomas J; Bello MJ; Alonso ME; Gonzalez-Gomez P; Arjona D; Kusak ME; de Campos JM; Sarasa JL; Rey JA Hum Pathol; 2002 Mar; 33(3):375-8. PubMed ID: 11979381 [TBL] [Abstract][Full Text] [Related]